ENBIFELIX Trademark

Trademark Overview


On Friday, January 11, 2019, a trademark application was filed for ENBIFELIX with the United States Patent and Trademark Office. The USPTO has given the ENBIFELIX trademark a serial number of 88258688. The federal status of this trademark filing is REGISTERED as of Tuesday, March 15, 2022. This trademark is owned by Samsung Bioepis Co., Ltd.. The ENBIFELIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis
enbifelix

General Information


Serial Number88258688
Word MarkENBIFELIX
Filing DateFriday, January 11, 2019
Status700 - REGISTERED
Status DateTuesday, March 15, 2022
Registration Number6669198
Registration DateTuesday, March 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Bioepis Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIncheon 21987
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIncheon 21987
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIncheon 21987
KR

Trademark Events


Event DateEvent Description
Tuesday, March 15, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 25, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, October 15, 2021ASSIGNED TO EXAMINER
Wednesday, October 13, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, March 25, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 8, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, July 15, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 14, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, July 11, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 11, 2019LETTER OF SUSPENSION E-MAILED
Thursday, July 11, 2019SUSPENSION LETTER WRITTEN
Saturday, July 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 6, 2019ASSIGNED TO LIE
Monday, July 1, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 28, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 28, 2019LETTER OF SUSPENSION E-MAILED
Thursday, March 28, 2019SUSPENSION LETTER WRITTEN
Tuesday, March 26, 2019ASSIGNED TO EXAMINER
Saturday, February 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 15, 2019NEW APPLICATION ENTERED IN TRAM